Accuray Incorporated  

(Public, NASDAQ:ARAY)   Watch this stock  
Find more results for Josh Levine
9.01
+0.40 (4.65%)
Apr 17 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 8.48 - 9.20
52 week 3.76 - 10.85
Open 8.57
Vol / Avg. 1.03M/897,947.00
Mkt cap 684.10M
P/E     -
Div/yield     -
EPS -0.95
Shares 75.93M
Beta 0.82
Inst. own 111%
Apr 30, 2014
Q3 2014 Accuray Incorporated Earnings Conference Call - 4:30PM EDT - Add to calendar
Apr 30, 2014
Q3 2014 Accuray Incorporated Earnings Release - 4:00PM EDT - Add to calendar
Mar 5, 2014
Accuray Incorporated at Cowen Health Care Conference - Webcast
Mar 5, 2014
Accuray Incorporated at Morgan Stanley European MedTech & Services Conference
Feb 26, 2014
Accuray Incorporated at Citi Global Healthcare Conference - Webcast
Jan 30, 2014
Q2 2014 Accuray Incorporated Earnings Conference Call - Webcast
Jan 30, 2014
Q2 2014 Accuray Incorporated Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin -5.81% -30.81%
Operating margin -0.76% -25.53%
EBITD margin - -14.56%
Return on average assets -4.55% -20.52%
Return on average equity -22.99% -64.38%
Employees 232 -
CDP Score - -

Address

1310 Chesapeake Terrace
SUNNYVALE, CA 94089
United States - Map
+1-408-7164600 (Phone)
+1-408-7164601 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Accuray, Inc. manufactures image-guided radiosurgery devices. The Company is based in the United States and its core product, the CyberKnife Stereotactic Radiosurgery System, combines image-guidance with robotics to offer unparalleled flexibility and accuracy. Accuray's focus is to revolutionize the treatment of solid cancers throughout the body by the precise delivery of high doses of radiation using the CyberKnife Stereotactic Radiosurgery System.

Officers and directors

Louis J. Lavigne Jr. Independent Chairperson of the Board
Age: 65
Bio & Compensation  - Reuters
Joshua H. Levine President, Chief Executive Officer, Director
Age: 55
Bio & Compensation  - Reuters
Elizabeth H. Davila Independent Vice Chairperson of the Board
Age: 69
Bio & Compensation  - Reuters
Gregory E. Lichtwardt Chief Financial Officer, Executive Vice President
Age: 59
Bio & Compensation  - Reuters
Kelly Londy Executive Vice President, Chief Commercial Officer
Age: 46
Bio & Compensation  - Reuters
Alaleh Nouri Interim General Counsel and Corporate Secretary
Bio & Compensation  - Reuters
Jack Goldstein Ph.D. Independent Director
Age: 66
Bio & Compensation  - Reuters
Richard R. Pettingill Independent Director
Age: 65
Bio & Compensation  - Reuters
Emad Rizk Independent Director
Age: 50
Bio & Compensation  - Reuters
Robert S. Weiss Independent Director
Age: 66
Bio & Compensation  - Reuters